Rochester, NY, United States of America

John J Varrone



 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: John J Varrone: Innovator in Monoclonal Antibody Research

Introduction

John J Varrone is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical applications.

Latest Patents

Varrone's latest patents include advancements in passive immunization for infections. These patents disclose monoclonal antibodies or binding portions that specifically target the aspp. autolysin N-acetylmuramoyl-L-alanine amidase catalytic domain and/or cell wall binding domain. The patents also describe pharmaceutical compositions containing these antibodies. Furthermore, they detail methods for using these monoclonal antibodies in the installation of orthopedic implants, grafts, or medical devices, as well as in treating or preventing infections and osteomyelitis. Diagnostic methods for detecting infections in samples are also included in his patents.

Career Highlights

John J Varrone is affiliated with the University of Rochester, where he continues to advance his research in monoclonal antibodies. His work has garnered attention for its potential applications in improving patient outcomes in various medical fields.

Collaborations

Throughout his career, Varrone has collaborated with esteemed colleagues, including John L Daiss and Edward M Schwarz. These collaborations have further enriched his research and contributed to the development of innovative medical solutions.

Conclusion

John J Varrone's contributions to monoclonal antibody research exemplify the impact of innovation in the medical field. His patents reflect a commitment to advancing healthcare through scientific discovery and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…